X0303 4 2010-11-09 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001502213 Chai-Onn Robert Roswell 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 0 1 0 0 EVP, GC & Corp. Sec. Common Shares, no par value 2010-11-09 4 S 0 35607 25.95 D 18511 D The common shares were sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on September 14, 2010. Represents long-term performance units (the "Performance Units") received upon conversion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") Performance Units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the Merger agreement between the issuer and, amongst others, old Valeant, less common shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.92 to $26.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, in each case upon request, full information regarding the number of shares sold at each separate price. Represents restricted share units received upon conversion of the reporting person's old Valeant restricted stock units that were held prior to the Merger, which were previously reported in Table I. By: Angie Palmer For: Robert Chai-Onn 2010-11-12